VaramirStart free · no cardSign in
CGON as of Nov 2 · 04:26 ET
CGONNasdaqBiological Products, (No Diagnostic Substances)

CG Oncology, Inc. · Brief

Next report

11 days

Nov 13 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±11.6%
avg realized
±4.0%
Nov 12 '24±11.1%▼−6.83%×0.62
Mar 28 '25±14.0%▼−1.93%×0.14
May 13 '25±8.5%▼−3.90%×0.46
Aug 8 '25±13.8%▲+2.05%×0.15
Nov 14 '25±10.0%▲+8.61%×0.86
Q1 FY26±10.7%▲+4.79%×0.45
May 8 '26±9.9%▲+0.64%×0.06
Q2 FY26±14.5%▲+3.36%×0.23
quarterimplied−15%0+15%realized×
Q2 FY26±14.5%▲+3.36%×0.23
May '26±9.9%▲+0.64%×0.06
Q1 FY26±10.7%▲+4.79%×0.45
Nov '25±10.0%▲+8.61%×0.86
Aug '25±13.8%▲+2.05%×0.15
May '25±8.5%▼−3.90%×0.46
2 older reports
Mar '25±14.0%▼−1.93%×0.14
Nov '24±11.1%▼−6.83%×0.62
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 13 report · est.

Bull2 of 3

233managers reporting a position in the latest quarterly filings13F · Jun 30 '26
4tracked funds holding CGONN-PORT · Aug 31 '26

Bear2

4 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
8 of 8recent reports where the move came in under the options implied rangeEarnings history
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

CGON report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 30impliedImplied move: ±19.4% into Nov 13 earnings (Oct 30 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.